Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) EBIT (2017 - 2025)

Historic EBIT for MedWellAI (MWAI) over the last 11 years, with Q3 2025 value amounting to -$326034.0.

  • MedWellAI's EBIT rose 4464.47% to -$326034.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.0 million, marking a year-over-year decrease of 23063.34%. This contributed to the annual value of -$2.8 million for FY2025, which is 6868.42% up from last year.
  • According to the latest figures from Q3 2025, MedWellAI's EBIT is -$326034.0, which was up 4464.47% from $62763.0 recorded in Q2 2025.
  • In the past 5 years, MedWellAI's EBIT registered a high of $630766.0 during Q3 2021, and its lowest value of -$22.1 million during Q2 2023.
  • In the last 5 years, MedWellAI's EBIT had a median value of -$606800.0 in 2022 and averaged -$3.1 million.
  • As far as peak fluctuations go, MedWellAI's EBIT plummeted by 474728.17% in 2021, and later soared by 459431.56% in 2025.
  • Over the past 5 years, MedWellAI's EBIT (Quarter) stood at -$331865.0 in 2021, then crashed by 84.01% to -$610649.0 in 2022, then skyrocketed by 45.03% to -$335679.0 in 2023, then tumbled by 113.5% to -$716662.0 in 2024, then surged by 54.51% to -$326034.0 in 2025.
  • Its last three reported values are -$326034.0 in Q3 2025, $62763.0 for Q2 2025, and -$1.0 million during Q1 2025.